QYUNS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
QYUNS-B: RESIGNATION OF NON-EXECUTIVE DIRECTOR
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
QYUNS-B: VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF SUPPLEMENTAL APPLICATION FOR QX001S (USTEKINUMAB INJECTION) FOR USE IN PEDIATRIC PLAQUE PSORIASIS
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
QYUNS-B: INSIDE INFORMATION ANNOUNCEMENTQX001S (SAILEXIN, USTEKINUMAB INJECTION)DRUG REGISTRATION CERTIFICATE APPROVED AND ISSUED BYTHE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
QYUNS-B: ACCEPTANCE BY THE CSRC OF APPLICATION FOR THECOMPANY'S H SHARE FULL CIRCULATION PLAN
QYUNS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
QYUNS-B: APPOINTMENT OF EMPLOYEE REPRESENTATIVE SUPERVISOR OFTHE SECOND SESSION OF THE SUPERVISORY COMMITTEE
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
QYUNS-B: FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETINGTO BE HELD ON FRIDAY, OCTOBER 25, 2024
QYUNS-B: RECORD DATE FOR EXTRAORDINARY GENERAL MEETING
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
QYUNS-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL DATA OF QX005N INJECTION FOR TREATMENT OF PRURIGO NODULARIS (PN) RELEASED AT THE 29TH ANNUAL MEETING OF CHINESE SOCIETY OF DERMATOLOGY
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
QYUNS-B: VOLUNTARY ANNOUNCEMENTFIRST SUBJECT ENROLLMENT FORQX005N PHASE III CLINICAL TRIAL FOR THE TREATMENT OF PRURIGONODULARIS
QYUNS-B: CLARIFICATION ANNOUNCEMENT SUPPLEMENTAL NOTICE AND REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024
QYUNS-B: REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024
No Data